Resumen de acción CLOV
Clover Health Investments, Corp. ofrece planes medicare advantage en Estados Unidos.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Clover Health Investments, Corp.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.69 |
| 52 Week High | US$1.63 |
| 52 Week Low | US$0.61 |
| Beta | 1.85 |
| 1 Month Change | -4.34% |
| 3 Month Change | -27.92% |
| 1 Year Change | -20.72% |
| 3 Year Change | -91.59% |
| 5 Year Change | n/a |
| Change since IPO | -93.19% |
Noticias y actualizaciones recientes
Recent updates
Clover Health Investments, Corp.'s (NASDAQ:CLOV) 26% Dip In Price Shows Sentiment Is Matching Revenues
Apr 20
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year
Mar 16Will Clover Health Investments (NASDAQ:CLOV) Spend Its Cash Wisely?
Mar 06Clover Health: Its Luck May Have Ran Out
Feb 26Here's Why We're Not Too Worried About Clover Health Investments' (NASDAQ:CLOV) Cash Burn Situation
Nov 21We're Hopeful That Clover Health Investments (NASDAQ:CLOV) Will Use Its Cash Wisely
Jul 07Chamath Palihapitiya-linked Clover Health Investments trading near all-time low
Oct 14Chamath Palihapitiya cuts stake in Clover Health to under 5%
Oct 04Rethinking My Clover Health Position
Sep 12Clover Paid The Price Of Its Alleged Lies; Time To Move On
Aug 17Clover Health Investments to name president Andrew Toy as CEO
Aug 08Clover Health Is A Buy Ahead Of Earnings
Jul 29Clover Health to expand Medicare Advantage plans to 13 additional counties, exit 2
Jul 15Is Clover Health A Good Healthcare Sector Stock Pick?
Jun 30Clover Set To Report Earnings Tonight: Levels To Watch
May 09Analysts Are Betting On Clover Health Investments, Corp. (NASDAQ:CLOV) With A Big Upgrade This Week
Mar 04Good News From Clover Health
Feb 25Clover Health Is Now Undervalued, But Gains Not Guaranteed
Jan 24Clover Health: Roles Reversed As Institutions Buy The Dip And Retail Investors Bottle Out
Dec 03Rentabilidad de los accionistas
| CLOV | US Healthcare | Mercado US | |
|---|---|---|---|
| 7D | 3.1% | -1.6% | 0.6% |
| 1Y | -20.7% | 0.06% | 23.9% |
Rentabilidad vs. Industria: CLOV obtuvo unos resultados inferiores a los del sector US Healthcare , que el año pasado arrojó un rendimiento del 1%.
Rentabilidad vs. Mercado: CLOV obtuvo unos resultados inferiores a los del mercado US, que fue del 24.9% el año pasado.
Volatilidad de los precios
| CLOV volatility | |
|---|---|
| CLOV Average Weekly Movement | 8.0% |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: El precio de las acciones de CLOV ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de CLOV (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2014 | 552 | Andrew Toy | www.cloverhealth.com/en/ |
Clover Health Investments, Corp. ofrece planes medicare advantage en Estados Unidos. Opera a través de dos segmentos: Seguros y No seguros. También ofrece Clover Assistant, una plataforma de software basada en la nube, que permite a los médicos detectar, identificar y gestionar antes las enfermedades crónicas; y el acceso a conocimientos basados en datos y personalizados para los pacientes que tratan.
Resumen de fundamentos de Clover Health Investments, Corp.
| Estadísticas fundamentales de CLOV | |
|---|---|
| Capitalización bursátil | US$344.58m |
| Beneficios(TTM) | -US$213.36m |
| Ingresos (TTM) | US$2.04b |
0.2x
Ratio precio-ventas (PS)-1.6x
Ratio precio-beneficio (PE)¿Está CLOV sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de CLOV | |
|---|---|
| Ingresos | US$2.04b |
| Coste de los ingresos | US$1.78b |
| Beneficio bruto | US$259.85m |
| Otros gastos | US$473.21m |
| Beneficios | -US$213.36m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 07, 2024
| Beneficios por acción (BPA) | -0.43 |
| Margen bruto | 12.76% |
| Margen de beneficio neto | -10.48% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado CLOV a largo plazo?
Ver rendimiento histórico y comparativa